pipette
ESEspañol

FKS1/2-variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infections

Hugh Gifford, Arnab Pradhan, Ben A Caswall, Sarah E. Murphy, Ian Leaves, Matt B. Edmondson, Tanmoy Chakraborty, Duncan Wilson, Surabhi K. Taori, Neil A. R. Gow, Rhys A. Farrer, Alistair J. P. Brown, Tihana A. Bicanic

Peer-reviewed journalReal-world use

In the authors' words

Abstract The emerging fungus Candida auris is a drug resistant global public health threat and WHO critical priority pathogen. Recommended first-line invasive candidiasis treatment is echinocandin monotherapy, but C. auris can develop on-treatment resistance via FKS1/2 gene mutations and additional, previously unexplained mechanisms. To better understand echinocandin failure in C. auris , we sequenced the genomes of echinocandin refractory FKS1/2 wild-type C. auris serial isolates from two critically unwell patients in London, UK. Population analysis profiling revealed echinocandin heteroresistance, and in vitro culture of clinical isolates at supra-MIC concentrations of anidulafungin (8 μg/ml) exhibited morphotypic heterogeneity. Small colony variants (SCVs) and large colony variants (LCVs) showed elevated MICs with polyploidy (to 4n and above) alongside adaptive changes in cell wall β−1,3-glucan content. LCVs contained significantly more mutations in calcineurin-related stress tolerance pathway gene CRZ1 compared to clinical parents and SCVs, associated with further increases in MIC. These findings indicate progressive step-wise accrual of adaptation to echinocandins, including genomic instability, alterations in stress tolerance pathways, and cell wall remodelling, paving the way for resistance emergence.

Main resultThe abstract does not state a limitation.

Appeared: Saturday, October 17. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-76954-x